Scarica l'app Stockscreener
6.30
2.02%
0.125
Dopo l'orario di chiusura:
6.18
-0.12
-1.90%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.175
Aprire:
$6.21
Volume 24 ore:
828.77K
Relative Volume:
0.47
Capitalizzazione di mercato:
$646.75M
Reddito:
-
Utile/perdita netta:
$-51.99M
Rapporto P/E:
-5.6477
EPS:
-1.1155
Flusso di cassa netto:
$-45.31M
1 W Prestazione:
+2.11%
1M Prestazione:
+1.12%
6M Prestazione:
+50.72%
1 anno Prestazione:
+135.96%
Intervallo 1D:
$6.08
$6.34
Intervallo di 1 settimana:
$5.91
$6.43
Portata 52W:
$2.3708
$7.11
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
6.30 | 634.43M | 0 | -51.99M | -45.31M | -1.1155 |
VRTX
Vertex Pharmaceuticals Inc
|
481.70 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
738.34 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
872.58 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
192.17 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
322.08 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2025-11-25 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-21 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
Franklin Resources (ACHV) group discloses 8.3% Achieve Life Sciences stake via funds - Stock Titan
Achieve Life Sciences Inc (ACHV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ACHV|Achieve Life Sciences Inc|Price:6.185|Chg%:+0.085 - TradingKey
BlackRock, Inc. (ACHV) discloses 5.1% beneficial stake in Achieve Life Sciences - Stock Titan
Achieve Life Sciences Inc (ACHV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Achieve Life Sciences, Inc. Revenue Breakdown – NASDAQ:ACHV - TradingView
Achieve Life Sciences Inc (ACHV) Income Statement - TradingKey
Achieve Life Sciences Inc (ACHV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Achieve Life Sciences, Inc. Revenue Breakdown – SWB:SP4P - TradingView
Achieve Life Sciences Inc (ACHV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ACHV Stock On Track To For Best Day In Over 7 Years — What’s Driving The Rally? - Stocktwits
Achieve Life Sciences Inc (ACHV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Achieve Life Sciences Inc (ACHV) Institutional Confidence - TradingKey
Achieve Life Sciences (ACHV) Q1 2026 earnings summary - Quartr
Achieve Life Sciences (ACHV) Registration filing Summary - Quartr
Achieve Life Sciences (ACHV) Corporate presentation Summary - Quartr
Achieve Life Sciences (ACHV) Proxy filing Summary - Quartr
Achieve Life Sciences (ACHV) Registration Filing Summary - Quartr
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Up 6.5%Here's Why - MarketBeat
Canaccord reiterates Achieve Life Sciences stock rating on CRL review By Investing.com - Investing.com Canada
Achieve Life Sciences (NASDAQ:ACHV) Trading Down 7.7%Should You Sell? - MarketBeat
Achieve Life Sciences Inc. (ACHV) Q1 2026 Earnings: EPS Beat Estimate as Company Advances Nicotine Cessation PipelineEarnings Revision Report - dars.gov.et
Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting - TradingView
Achieve Life Sciences Inc. (ACHV) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Vivo Opportunity group reports 5.0% stake in Achieve Life Sciences | ACHV SEC FilingForm SCHEDULE 13G - Stock Titan
Achieve Life Sciences Joins Russell 2000 Index - 富途牛牛
Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able (NASDAQ:ACHV) - Seeking Alpha
Achieve Life Sciences, Inc. Amends Certificate of Incorporation – SEC 8-K Filing Details and Company Information - Minichart
[8-K] ACHIEVE LIFE SCIENCES, INC. Reports Material Event - Stock Titan
ACHVAchieve Life Sciences Inc Latest SEC Filings - Finviz
Achieve Life Sciences Inc Annual Shareholders Meeting Transcript - GuruFocus
Achieve Life Sciences, Inc.(NasdaqCM:ACHV) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2500 Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2000 Index - marketscreener.com
Achieve Life Sciences added to Russell 2000 index By Investing.com - Investing.com Nigeria
Achieve Life Sciences (ACHV) Joins Russell 2000 Index - GuruFocus
Achieve Life Sciences added to Russell 2000 index - Investing.com
Achieve Life Sciences Joins Russell 2000® Index - The Manila Times
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2000 Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 3000E Index - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 3000E Growth Benchmark - marketscreener.com
Enterprise value to revenue forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Enterprise value to EBIT forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Price to earnings forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 3000 Index - marketscreener.com
Price to sales forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Enterprise value to EBITDA forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Price to book forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 3000 Growth Benchmark - marketscreener.com
Achieve Life Sciences (ACHV) Receives Strong Buy Rating with $20 Target - GuruFocus
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Achieve Life Sciences Inc Azioni (ACHV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Oki Mark K | Chief Financial Officer |
Sep 18 '25 |
Sale |
2.92 |
50,060 |
146,175 |
127,940 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Option Exercise |
0.00 |
297,500 |
0 |
358,376 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Sale |
2.92 |
129,501 |
378,143 |
228,875 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
34,100 |
0 |
46,764 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Sale |
2.77 |
14,070 |
38,974 |
32,694 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Option Exercise |
0.00 |
455,000 |
0 |
455,000 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Sale |
2.77 |
139,858 |
387,407 |
315,142 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Option Exercise |
0.00 |
110,000 |
0 |
143,214 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Sale |
2.77 |
27,629 |
76,532 |
115,585 |
| Xinos Jaime | Chief Commercial Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
69,000 |
0 |
95,286 |
0.11%
5.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):